Table 4.
Timepoint | Measurement | MenC (μg/ml) | MenW (μg/ml) | MenY (μg/ml) |
---|---|---|---|---|
28 days | IgG1 [95% CI] | 3.1 [2.53–3.85] | 0.4 [0.30–0.52] | 2.3 [1.80–2.83] |
IgG2 [95% CI] | 5.1 [3.84–6.67]***,a | 0.7 [0.49–1.03]***,a | 1.4 [0.97–1.92]**,a | |
IgG1/IgG2 ratio [95% CI] | 0.6 [0.48–0.81] | 0.6 [0.40–0.76] | 1.6 [1.19–2.21] | |
1 year | IgG1 [95% CI] | 1.0 [0.82–1.16] | 0.6 [0.40–0.76] | 1.6 [1.30–1.98] |
IgG2 [95% CI] | 1.2 [0.85–1.47] | 0.8 [0.63–1.11]**,b | 0.8 [0.62–1.13]***,b | |
IgG1/IgG2 ratio [95% CI] | 0.8 [0.65–1.10] | 0.7 [0.50–0.87] | 1.9 [1.41–2.51] |
Geometric mean concentrations [95% CI] are indicated. Meningococcal group-specific IgG1 and IgG2 responses at the different time points were compared with the Mann–Whitney U test.
**p < 0.01, ***p < 0.001.
aIgG2 vs IgG1 at day 28.
bIgG2 vs IgG1 at 1 year.